Tiacci, E; Park, J.H.; De Carolis, L.; Chung, S.S.; Broccoli, A.; Scott, S.; Zaja, F.; Devlin, S.; Pulsoni, A.; Chung, Y.R.; Cimminiello, M.; Kim, E.; Rossi, D.; Stone, R.M.; Motta, G.; Saven, A.; Varettoni, M.; Altman, J.K.; Anastasia, A.; Grever, M.R.; Ambrosetti, A.; Rai, K.R.; Fraticelli, V.; Lacouture, M.E.; Carella, A.M.; Levine, R.L.; Leoni, P.; Rambaldi, A.; Falzetti, F.; Ascani, S.; Capponi, M.; Martelli, M.P.; Park, C.Y.; Pileri, S.A.; Rosen, N.; Foà, R.; Berger, M.F.; Zinzani, P.L.; Abdel-Wahab, O.; Falini, B.; Tallman, M.S., Targeting mutant BRAF in relapsed or refractory hairy-cell leukemia, «THE NEW ENGLAND JOURNAL OF MEDICINE», 2015, 373, pp. 1733 - 1747 [Scientific article]
Zinzani P.L.; Broccoli A., T-Cell Lymphoproliferative Disorders, in: Postgraduate Haematology, Seventh Edition, Hoboken, John Wiley & Sons Inc, 2015, pp. 524 - 536 [Chapter or essay]
P. L. Zinzani;A. Broccoli;B. Casadei;V. Stefoni;C. Pellegrini;L. Gandolfi;R. Maglie;L. Argnani;S. Pileri;S. Fanti, The role of rituximab and positron emission tomography in the treatment of primary mediastinal large B-cell lymphoma: experience on 74 patients, «HEMATOLOGICAL ONCOLOGY», 2015, 33, pp. 145 - 150 [Scientific article]
Zinzani, Pl; Stefoni, V; Broccoli, A; Pellegrini, C; Gandolfi, L; Casadei, B; Maglie, R; Pileri, S; Argnani, L., Is it really possible to cure hairy cell leukemia patients only with frontline therapy?, «ANNALS OF HEMATOLOGY», 2014, 93, pp. 1565 - 1569 [Scientific article]
Pellegrini Cinzia, Argnani Lisa, Broccoli Alessandro, Stefoni Vittorio, Derenzini Enrico, Gandolfi Letizia, Casadei Beatrice, Maglie Roberto, Pileri Stefano, Zinzani Pier Luigi., Prognostic value of interim positron emission tomography in patients with peripheral T-cell lymphoma., «THE ONCOLOGIST», 2014, 19, pp. 746 - 750 [Scientific article]
Derenzini E, Casadei B, Broccoli A, Gandolfi L, Pellegrini C, Zinzani PL., Sequential therapy with alternating short courses of R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone) and R-FM (rituximab, fludarabine, mitoxantrone) followed by autologous stem cell transplantation results in long term remission in advanced follicular lymphoma., «BRITISH JOURNAL OF HAEMATOLOGY», 2014, 166, pp. 625 - 628 [Scientific article]
Broccoli A;Pellegrini C;Celli M;Argnani L;Agostinelli C;Pileri S;Zinzani PL, Single-Agent Lenalidomide Is Effective in the Treatment of a Heavily Pretreated and Refractory Angioimmunoblastic T-Cell Lymphoma Patient., «CLINICAL LYMPHOMA MYELOMA & LEUKEMIA», 2014, 14, pp. 119 - 122 [Scientific article]
Broccoli A;Stanzani M;Bandini G;Bonifazi F;Stefoni V;Pellegrini C;Derenzini E;Gandolfi L;Quirini F;Argnani L;Tschon M;Casadei B;Baccarani M;Zinzani PL, Allotransplant in relapsed or refractory aggressive T-cell lymphomas: retrospective monocentric analysis of 14 patients, «LEUKEMIA & LYMPHOMA», 2013, 54, pp. 1791 - 1793 [Scientific article]
Gentile G;Broccoli A;Brunocilla E;Schiavina R;Borghesi M;Romagnoli D;Bianchi L;Derenzini E;Agostinelli C;Franceschelli A;Colombo F;Zinzani PL, An isolated penile mass in a young adult turned out to be a primary marginal zone lymphoma of the penis. A case report and a review of literature., «ANTICANCER RESEARCH», 2013, 33, pp. 2639 - 2642 [Scientific article]
Zinzani PL;Derenzini E;Pellegrini C;Celli M;Broccoli A;Argnani L, Bendamustine efficacy in Hodgkin lymphoma patients relapsed/refractory to brentuximab vedotin., «BRITISH JOURNAL OF HAEMATOLOGY», 2013, 163, pp. 681 - 683 [Scientific article]
Zinzani P.L.;Pellegrini C.;Merla E.;Ballerini F.;Fabbri A.; Guarini A.;Pavone V.;Quintini G.;Puccini B.;Vigliotti M.L.; Stefoni V.; Derenzini E.;Broccoli A.;Gandolfi L.;Quirini F.;Casadei B.;Argnani L.;Baccarani M., Bortezomib as salvage treatment for heavily pretreated relapsed lymphoma patients: a multicenter retrospective study, «HEMATOLOGICAL ONCOLOGY», 2013, 31, pp. 179 - 182 [Scientific article]
Derenzini E; Stefoni V; Maglie R; Casadei B; Pellegrini C; Broccoli A; Stefani G; Fanti S; Motta MR; Narducci R; Argnani L; Zinzani PL., Collection of Hematopoietic Stem Cells after Previous Radioimmunotherapy is Feasible and Does Not Impair Engraftment after Autologous Stem Cell Transplantation in Follicular Lymphoma., «BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION», 2013, 19, pp. 1695 - 1701 [Scientific article]
Broccoli A;Derenzini E;Pellegrini C;Narducci R;Stefani G;Casadei B;Argnani L;Zinzani PL, Complete response of relapsed systemic and cutaneous anaplastic large cell lymphoma using brentuximab vedotin: 2 case reports., «CLINICAL LYMPHOMA MYELOMA & LEUKEMIA», 2013, 13, pp. 493 - 495 [Scientific article]
Zinzani PL; Pellegrini C; Gandolfi L; Casadei B; Derenzini E; Broccoli A; Quirini F; Argnani L; Pileri S; Celli M; Fanti S; Poletti V; Stefoni V; Baccarani M., Extranodal marginal zone B-cell lymphoma of the lung: experience with fludarabine and mitoxantrone-containing regimens., «HEMATOLOGICAL ONCOLOGY», 2013, 31, pp. 183 - 188 [Scientific article]
Zinzani PL;Pellegrini C;Broccoli A;Casadei B;Argnani L;Pileri S, Fludarabine-mitoxantrone-rituximab regimen in untreated intermediate/high-risk follicular non-Hodgkin's lymphoma: experience on 142 patients., «AMERICAN JOURNAL OF HEMATOLOGY», 2013, 88, pp. 273 - 276 [Scientific article]
